Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Robert A. Hauser »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Rob Smith < Robert A. Hauser < Robert A. Schoevers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000117 (2014) Robert A. Hauser [États-Unis] ; Mark Forrest Gordon [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Paolo Barone [Italie] ; Anthony H. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Catherine Debieuvre [France] ; Mandy Fr Dorf [Allemagne]Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
000125 (2014) John P. Seibyl [Oman] ; Andreas Kupsch [Allemagne] ; Jan Booij [Pays-Bas] ; Donald G. Grosset [Royaume-Uni] ; Durval C. Costa [Portugal] ; Robert A. Hauser [États-Unis] ; Jacques Darcourt [France] ; Nin Bajaj [Royaume-Uni] ; Zuzana Walker [Royaume-Uni] ; Kenneth Marek [États-Unis] ; Ian Mckeith [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Klaus Tatsch [Allemagne] ; Eduardo Tolosa [Espagne] ; Rudi A. Dierckx ; Igor D. Grachev [États-Unis]Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
000328 (2010) Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
000334 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000342 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000543 (2003) Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Parkinson disease
3Dopamine agonist
3Nervous system diseases
3Parkinson's disease
2Aged
2Female
2Humans
2Male
2Middle Aged
2Pramipexole
2Release
2Time Factors
2dopamine agonist
1Adult
1Aged, 80 and over
1Agonist
1Aminoacid
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Benzothiazoles (administration & dosage)
1Benzothiazoles (adverse effects)
1Cartography
1Catecholamine
1Clinical Trials as Topic
1Comparative study
1Confidence Intervals
1D2 Dopamine receptor
1Delayed-Action Preparations (therapeutic use)
1Dementia (diagnostic imaging)
1Dopa
1Dopamine
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Drug Administration Schedule
1Dyskinesia
1Emission tomography
1Evaluation
1Follow-Up Studies
1Force
1Human
1Injections
1Levodopa
1Multicenter Studies as Topic
1Nortropanes (administration & dosage)
1Observer Variation
1Parkinson Disease (drug therapy)
1Parkinsonian Disorders (diagnostic imaging)
1Positron
1Prognosis
1Putamen
1Recommendation
1Reliability
1Ropinirole
1Safety
1Sensitivity and Specificity
1Severity of Illness Index
1Tomography, Emission-Computed, Single-Photon
1Treatment
1Uptake
1Validity
1Young Adult
1clinimetrics
1dyskinesia
1pramipexole extended release
1pramipexole‐extended release
1rating scales
1reliability
1switch trial
1treatment
1validity

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Robert A. Hauser" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Robert A. Hauser" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Robert A. Hauser
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024